Prosecution Insights
Last updated: October 25, 2026

Viering, Jentschura & Partner Mbb - Sonstige

Technology area: Semiconductors, Circuits & Optics

6 pending office actions • 6 clients • 6 examiners • 6 art units • 0 of 6 (0%) have an AI response strategy ready • 32 patents granted in the last 365 days

Analysis

VIERING, JENTSCHURA & PARTNER mbB - sonstige reports 6 pending office actions in Semiconductors, Circuits & Optics and 2035 career applications. The current docket is presented within a broader reported application base.

The resolved allowance rate is 90.02%, with an average of 3.24 office actions per allowance. Practitioners can use the rate to review resolved outcomes and the action average to plan for repeated examination activity before allowance.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=2035 apps, methodology: how we score firms)

90.0%
Allowance Rate
n=2035
+0.53σ
Allowance Rate (norm)
n=2035
3.2
OAs to Allowance
n=1407
-0.18σ
OAs to Allow (norm)
n=1407
1023 days
Time to Allowance
n=1407
-1.1pp
Interview Lift
n=2035
21.4%
RCE Rate
n=2035
0.5%
Appeal Rate
n=2035

Rejection Performance (% of received rejections ultimately overcome)

78.4%
§101 Overcome
n=176
83.2%
§102 Overcome
n=779
81.8%
§103 Overcome
n=1177
83.4%
§112 Overcome
n=651

Specialization & Scale

H04W, G06F, H04B
Top CPC Subclasses
17%
Top-3 CPC Share
n=2035
0
Practitioners
n=2035
—
Apps / Practitioner
n=2035 (min 20)

Portfolio Summary

6
Total Pending OAs
3
Non-Final OAs
2
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (67%)
2
Medium (33%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (33%)
Multi-statute (no §101)4 (67%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
17% of docket
1
Information Tech
17% of docket
0
Communications
0% of docket
2
Semiconductors
33% of docket
2
Mechanical / Eng
33% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BOUIZZA, MICHAEL M 1 81.6% +13.8%
CROSS, JULIANA MARIA 1 83.1% +17.7%
TSO, STANLEY 1 75.5% +34.3%
TSAI, JAMES T 1 63.5% +56.9%
CRAIGO, WILLIAM A 1 48.9% +38.1%
SHOSTAK, ANDREY 1 52.4% +61.8%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18836377 COMMUNICATION APPARATUS BOUIZZA, MICHAEL M —

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18006164 CRYSTALLINE ZIRCONIUM PHOSPHATE FOR USE IN THERAPY, PHARMACEUTICAL COMPOSITION, AND USE OF THE SAME CRAIGO, WILLIAM A 26d overdue
18724645 MULTILAYER SUBSTRATE AND JIG TSO, STANLEY 27d
18915182 APPARATUS, SYSTEM, AND METHOD OF FUNCTIONAL SAFETY DETECTOR FOR RADAR PROCESSING PATH CROSS, JULIANA MARIA —
17429923 DEVICE FOR SKIN BIOPSY SHOSTAK, ANDREY —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18006164 CRYSTALLINE ZIRCONIUM PHOSPHATE FOR USE IN THERAPY, PHARMACEUTICAL COMPOSITION, AND USE OF THE SAME CRAIGO, WILLIAM A 26d overdue
18724645 MULTILAYER SUBSTRATE AND JIG TSO, STANLEY 27d
18836377 COMMUNICATION APPARATUS BOUIZZA, MICHAEL M —
18915182 APPARATUS, SYSTEM, AND METHOD OF FUNCTIONAL SAFETY DETECTOR FOR RADAR PROCESSING PATH CROSS, JULIANA MARIA —
18692372 DEVICE AND METHOD FOR CONTROLLING A ROBOT DEVICE TSAI, JAMES T —
17429923 DEVICE FOR SKIN BIOPSY SHOSTAK, ANDREY —

Client Portfolio (6 clients)

Top Art Units

Art UnitApps
28451
36481
28471
21471
16151
37911

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18836377 COMMUNICATION APPARATUS Kyocera Corporation BOUIZZA, MICHAEL M 2845 §103 Final Rejection — Pending Feb 05, 2025
18915182 APPARATUS, SYSTEM, AND METHOD OF FUNCTIONAL SAFETY DETECTOR FOR RADAR PROCESSING PATH Mobileye Vision Technologies Ltd. CROSS, JULIANA MARIA 3648 §102§103 Non-Final OA — Pending Oct 14, 2024
18724645 MULTILAYER SUBSTRATE AND JIG Nidec Advance Technology Corporation TSO, STANLEY 2847 §102§103 Non-Final OA 27d Pending Jun 27, 2024
18692372 DEVICE AND METHOD FOR CONTROLLING A ROBOT DEVICE Dconstruct Technologies Pte. Ltd. TSAI, JAMES T 2147 §103 Non-Final OA — Pending Mar 15, 2024
18006164 CRYSTALLINE ZIRCONIUM PHOSPHATE FOR USE IN THERAPY, PHARMACEUTICAL COMPOSITION, AND USE OF THE SAME Cj Tech Holdings Pte. Ltd. CRAIGO, WILLIAM A 1615 §102§103 Final Rejection 26d overdue Pending Jan 20, 2023
17429923 DEVICE FOR SKIN BIOPSY Singapore University Of Technology And Design SHOSTAK, ANDREY 3791 §103§112 Non-Final OA — Pending Aug 10, 2021

Managing Viering, Jentschura & Partner Mbb - Sonstige's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Viering, Jentschura & Partner Mbb - Sonstige's patent allowance rate?

90.0% of resolved applications prosecuted by Viering, Jentschura & Partner Mbb - Sonstige were allowed, across 2,035 applications in USPTO records.

How many office actions does Viering, Jentschura & Partner Mbb - Sonstige average before allowance?

3.24 office actions per allowed application on average.

How many pending office actions does Viering, Jentschura & Partner Mbb - Sonstige have?

6 pending office actions as of October 2026, for 6 clients, before 6 examiners in 6 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month